A Randomized Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Phase of Trial: Phase III
Latest Information Update: 13 Mar 2018
At a glance
- Drugs Vinorelbine (Primary) ; Anastrozole; Letrozole
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Mar 2018 Planned End Date changed from 1 Feb 2023 to 1 Feb 2024.
- 08 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 11 Apr 2016 New trial record